According to the official WeChat account of Jilin TV Station: On the 26th, the Changchun Municipal People's Procuratorate filed a public prosecution in the Changchun Intermediate People's Court of Cui Honghai (director level), the former party secretary and director of the Jilin Provincial Food and Drug Administration, who was suspected of accepting bribes.

During the review and prosecution stage, the procuratorial organ informed Cui Honghai of his litigation rights according to law, interrogated Cui Honghai according to law, listened to the opinions of his defender, and reviewed all case materials.

The indictment of the Changchun People's Procuratorate charged: Cui Honghai took advantage of his position to seek benefits for others and illegally accepted property from others. He should be investigated for criminal responsibility for the crime of accepting bribes according to law.

Zheng Shi (WeChat ID: xjbzse) noticed that Cui Honghai had served as Party Secretary and Director of the Food and Drug Administration of Jilin Province from July 2003 to January 2017.

According to the public resume, Cui Honghai, Manchu, was born in September 1960.After August 1998, he served as Secretary of the Party Leadership Group and Director of the Tonghua Industrial and Commercial Bureau. In April 2004, he was transferred to be a member of the Party Leadership Group and Deputy Director of the Jilin Provincial Industrial and Commercial Bureau.

In June 2011, with the approval of the Jilin Provincial Party Committee and the Provincial Government, the Jilin Provincial Food Safety Committee Office was established as a permanent office of the Jilin Provincial Food Safety Committee.The following year, he served as secretary of the party group and deputy director of the office, and was designated as the director of the department.

In July 2013, Cui Honghai served as secretary of the party group and director (director) of the Jilin Provincial Food and Drug Administration (Office of the Provincial Food and Drug Safety Committee).

At present, when Changsheng Biotech produced the DPT problem vaccine with the batch number 201605014-01, Cui Honghai was serving as the director of the Jilin Provincial Food and Drug Administration.

In January last year, Cui Honghai was transferred to the party secretary and chairman of Northeast SME Credit Re-Guarantee Co., Ltd.But seven months later, Cui Honghai was investigated.

In December last year, Cui Honghai was double fired by the Jilin Provincial Commission for Discipline Inspection.According to the report, Cui Honghai seriously violated national laws and regulations, took advantage of his position to seek benefits for others in business operations, contracting projects, etc., and accepted property, and was suspected of accepting bribes.

The report also stated that Cui Honghai, as a party member and leading cadre, has lost his ideals and beliefs, has an indifferent concept of law and discipline, inflated selfish desires, abused power for personal gain, seriously violated party discipline, and was suspected of crimes.

Cui Honghai's successor, Guo Hongzhi, the current director of Jilin Provincial Food and Drug Administration, has also served in Jilin Provincial Food and Drug Administration for a long time.

After the vaccine incident, the Food and Drug Administration of Jilin Province has withdrawn the GMP certificate of Changchun Changsheng rabies vaccine drug, stopped the production and sales of rabies vaccine of the company, and suspended the batch release of all products of the company.

On July 23, in order to implement the spirit of the important instructions issued by the General Secretary of the CPC Central Committee and Premier Li Keqiang on the illegal production of rabies vaccine by Changchun Changsheng Biotechnology Co., Ltd., the investigation team of the State Council rushed to Jilin to carry out the illegal production of rabies vaccine by Changchun ChangshengCase investigation work.

On July 24, Bi Jingquan, leader of the investigation team of the State Council, secretary of the party group and deputy director of the State Administration for Market Regulation, presided over the first plenary meeting of the investigation team.

The meeting requested that the work should focus on seven aspects.The first is to thoroughly investigate the violations of laws and regulations of the companies involved in the case, fully investigate the facts of violations and the flow of vaccines involved in the case, and do a good job in the investigation and evidence collection; the second is to severely punish illegal and criminal acts in accordance with the law, seriously investigate and deal with the companies involved in the case, and severely punish the directly responsible persons and other personnel involved in the case in accordance with the lawThe third is to investigate the performance of public officials, and those who find dereliction of duty must be held accountable; the fourth is to scientifically carry out risk assessment, research and propose relief measures for classified treatment; fifth, to properly handle the follow-up work of the enterprises involved; sixth, to respondIn response to social concerns, the progress of case investigations shall be announced in a timely manner, and scientific knowledge of vaccine safety shall be popularized; Seventh, work measures for reforming and improving the vaccine management system shall be studied, and a long-term mechanism for ensuring vaccine quality and safety shall be established and improved.According to work needs, the investigation team consists of working groups such as the case investigation team, the supervisory responsibility team, the comprehensive team and the expert team.